Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fortis Malar HospitalsBOM:523696 -2.42%31 Return-on-Tangible-Asset is 1.62% as of Jun. 2026, which is 71% above its 10-year median of 0.95. GuruFocus rates BOM:523696 with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 685 Healthcare Providers & Services companies, Fortis Malar Hospitals ranks worse than 62.19% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Fortis Malar Hospitals's annualizedNet Income for the quarter that ended in Jun. 2026 was ₹6.09 Mil. Fortis Malar Hospitals's average total tangible assets for the quarter that ended in Jun. 2026 was ₹376.03 Mil. Therefore, Fortis Malar Hospitals's annualized Return-on-Tangible-Asset for the quarter that ended in Jun. 2026 was 1.62%.
The historical rank and industry rank for Fortis Malar Hospitals's Return-on-Tangible-Asset or its related term are showing as below:
BOM:523696'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -10.39 Med: 0.95 Max: 35.73
Current: 0.37
During the past 13 years, Fortis Malar Hospitals's highest Return-on-Tangible-Asset was 35.73%. The lowest was -10.39%. And the median was 0.95%.
BOM:523696's Return-on-Tangible-Asset is ranked worse than 62.19% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 2.61
vs BOM:523696: 0.37
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Fortis Malar Hospitals Return-on-Tangible-Asset Related Terms
Fortis Malar Hospitals Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Fortis Malar Hospitals's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:523696 vs HCA, THC, EHC: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, Fortis Malar Hospitals's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fortis Malar Hospitals Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fortis Malar Hospitals's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Fortis Malar Hospitals's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Jun. 2026) net income data.
What does a Return-on-Tangible-Asset of 1.62% mean?
Fortis Malar Hospitals (BOM:523696) has a Return-on-Tangible-Asset of 1.62% as of Jun. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fortis Malar Hospitals and its competitors. This is 71% above median its historical median of 0.95. According to the industry distribution chart, Fortis Malar Hospitals ranks #426 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 62.2%.
Is Fortis Malar Hospitals' Return-on-Tangible-Asset too high?
Fortis Malar Hospitals' current Return-on-Tangible-Asset of 1.62% is 71% above median its 10-year median of 0.95. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.61. Fortis Malar Hospitals' value of 1.62% is 37.9% below this industry median. Based on the distribution chart, Fortis Malar Hospitals ranks #426 out of 685 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Fortis Malar Hospitals has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Fortis Malar Hospitals' Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fortis Malar Hospitals ranks #426 out of 685 companies for Return-on-Tangible-Asset. This places Fortis Malar Hospitals in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.61. Fortis Malar Hospitals' value of 1.62% is 37.9% below this benchmark. While the company's 10-year median is 0.95 vs. the industry median of 2.61, Fortis Malar Hospitals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.61, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fortis Malar Hospitals's current Return-on-Tangible-Asset of 1.62% is 37.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Fortis Malar Hospitals and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fortis Malar Hospitals's current Return-on-Tangible-Asset is 1.62%, which is 71% above median its own 10-year median of 0.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortis Malar Hospitals stock overvalued right now?
Fortis Malar Hospitals (BOM:523696) has a current Return-on-Tangible-Asset of 1.62%. The current Return-on-Tangible-Asset is 1.62%, which is 71% above median its 10-year median of 0.95 and 37.9% below the Healthcare Providers & Services industry median of 2.61. Fortis Malar Hospitals' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Fortis Malar Hospitals (BOM:523696), the current Return-on-Tangible-Asset is 1.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Fortis Malar Hospitals Ltd is an India-based company engaged in the provision of healthcare services. It focuses on providing medical care in the areas of cardiology and cardiac surgery, neurosurgery, gynecology, orthopedics, gastroenterology, neurology, pediatrics, diabetes, nephrology, and internal medicine. The company provides healthcare services in various branches of medicine such as general surgery, general medicine, pediatrics, neurology, cardiology, ophthalmology, radiology, pathology, gastroenterology, urology, thoracic surgery, plastic surgery, and other allied specialties. It operates in one business, namely, in the health care services.
31GF Score
Get the complete analysis for BOM:523696
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:523696 has been successfully added to your 
